Development stage

1

Assets whose furthest-along trial is at this stage.

RadiopharmaceuticalPhase 1

RadiopharmaceuticalPhase 1

RadiopharmaceuticalPhase 1

RadiopharmaceuticalPhase 1

RadiopharmaceuticalPhase 1

RadiopharmaceuticalPhase 1

Gene therapy / editingPhase 1No recent activity

Protein / enzyme therapeuticPhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1No recent activity

Antibody-derived scaffoldPhase 1

Unknown / undisclosedPhase 1

AD-236A + AD-236B

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1No recent activity

Monoclonal antibodyPhase 1

RNA / oligonucleotidePhase 1

Gene therapy / editingPhase 1No recent activity

CombinationPhase 1

Small moleculePhase 1

Small moleculePhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Monoclonal antibodyPhase 1

Cell therapyPhase 1

RNA / oligonucleotidePhase 1

RNA / oligonucleotidePhase 1

Small moleculePhase 1

Antibody–drug conjugatePhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Cell therapyPhase 1

Small moleculePhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Monoclonal antibodyPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

AST2303 ABK3376

Small moleculePhase 1

ATH-399A (HL192)

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Multispecific antibodyPhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

AV000103A (ICVAX)

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Unknown / undisclosedPhase 1No recent activity

Small moleculePhase 1

Small moleculePhase 1

AZD4604 for oral administration

Unknown / undisclosedPhase 1No recent activity

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Antibody–drug conjugatePhase 1

Actinium Ac 225-DOTA-Daratumumab

Monoclonal antibodyPhase 1

Allo-RevCAR01-T

Unknown / undisclosedPhase 1

Anhui HygeianCells EE001

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1No recent activity

Anti-CD123 CAR NK cells

Unknown / undisclosedPhase 1

Small moleculePhase 1

Atorvo+ · Atorvo+

Small moleculePhase 1

Azercabtagene zapreleucel (azer-cel)

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1No recent activity

Small moleculePhase 1No recent activity

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Multispecific antibodyPhase 1

Multispecific antibodyPhase 1

BCMA CAR-NK (Shenzhen Pregene Biopharma)

Cell therapyPhase 1

BCMA-CD19 compound CAR (cCAR) T cells

Cell therapyPhase 1

Small moleculePhase 1

Small moleculePhase 1No recent activity

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1No recent activity

Antibody–drug conjugatePhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Biologic — subtype unspecifiedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Monoclonal antibodyPhase 1

BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide

Unknown / undisclosedPhase 1

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Bemdaneprocel (MSK-DA01)

Cell therapyPhase 1

Small moleculePhase 1

Brexpiprazole long-acting injection (Kelun)

Small moleculePhase 1

Monoclonal antibodyPhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Monoclonal antibodyPhase 1

CAR-GPRC5D (RD118, IASO Biotherapeutics)

Cell therapyPhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Unknown / undisclosedPhase 1

CD19/CD20/BCMA CAR-T (Shanghai Cell Therapy Group)

Cell therapyPhase 1

Multispecific antibodyPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1No recent activity

Small moleculePhase 1No recent activity

Monoclonal antibodyPhase 1

Unknown / undisclosedPhase 1

Monoclonal antibodyPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1No recent activity

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Monoclonal antibodyPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1No recent activity

PeptidePhase 1No recent activity

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Gene therapy / editingPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Gene therapy / editingPhase 1

Cell therapyPhase 1

Ceramide NanoLiposome (Ceraxa)

Unknown / undisclosedPhase 1

Small moleculePhase 1No recent activity

Cupistem / ALLO-ASC · Cupistem (autologous, approved in Korea)

Cell therapyPhase 1

Small moleculePhase 1No recent activity

Biologic — subtype unspecifiedPhase 1

BotanicalPhase 1

Small moleculePhase 1No recent activity

Monoclonal antibodyPhase 1

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

RNA / oligonucleotidePhase 1

Small moleculePhase 1

Multispecific antibodyPhase 1

Small moleculePhase 1

Small moleculePhase 1

DehydraTECH-CBD/semaglutide

Small moleculePhase 1

Microbiome therapeuticPhase 1

Small moleculePhase 1

Multispecific antibodyPhase 1

Small moleculePhase 1

Small moleculePhase 1

Cell therapyPhase 1

Small moleculePhase 1

Small moleculePhase 1No recent activity

Small moleculePhase 1

Unknown / undisclosedPhase 1

Antibody–drug conjugatePhase 1No recent activity

Cell therapyPhase 1

Cell therapyPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1No recent activity

Unknown / undisclosedPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Biologic — subtype unspecifiedPhase 1

Multispecific antibodyPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1No recent activity

Monoclonal antibodyPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Globalagliatin Hydrochloride

Small moleculePhase 1No recent activity

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Antibody–drug conjugatePhase 1

Small moleculePhase 1

PeptidePhase 1No recent activity

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Multispecific antibodyPhase 1

Antibody–drug conjugatePhase 1

PeptidePhase 1No recent activity

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Multispecific antibodyPhase 1

Small moleculePhase 1

RNA / oligonucleotidePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1No recent activity

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Antibody–drug conjugatePhase 1

Small moleculePhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Cell therapyPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Antibody–drug conjugatePhase 1

IM21 CAR-T cells

Cell therapyPhase 1No recent activity

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Small moleculePhase 1

RadiopharmaceuticalPhase 1

Small moleculePhase 1No recent activity

Small moleculePhase 1

Protein / enzyme therapeuticPhase 1

Monoclonal antibodyPhase 1

RNA / oligonucleotidePhase 1

Small moleculePhase 1

Gene therapy / editingPhase 1

Multispecific antibodyPhase 1

Cell therapyPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Cell therapyPhase 1

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Antibody–drug conjugatePhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Biologic — subtype unspecifiedPhase 1

Gene therapy / editingPhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Small moleculePhase 1

KRAS-specific Autologous TCR-T cell

Cell therapyPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Antibody–drug conjugatePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Gene therapy / editingPhase 1

Small moleculePhase 1No recent activity

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

RNA / oligonucleotidePhase 1

Small moleculePhase 1

RNA / oligonucleotidePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Antibody–drug conjugatePhase 1

Small moleculePhase 1

Antibody–drug conjugatePhase 1

Unknown / undisclosedPhase 1

Antibody–drug conjugatePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Levodopa Cyclops

CombinationPhase 1

Lobeglitazone · Duvie

Small moleculePhase 1

Long-acting ANP analog (LY3971297)

Small moleculePhase 1

Microbiome therapeuticPhase 1

Antibody–drug conjugatePhase 1

Multispecific antibodyPhase 1

Multispecific antibodyPhase 1

Multispecific antibodyPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1No recent activity

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Protein / enzyme therapeuticPhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Biologic — subtype unspecifiedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1No recent activity

Multispecific antibodyPhase 1

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Biologic — subtype unspecifiedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

OrcaGraft (Orca-Q)

Unknown / undisclosedPhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Monoclonal antibodyPhase 1No recent activity

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Antibody–drug conjugatePhase 1

Antibody–drug conjugatePhase 1

Antibody–drug conjugatePhase 1

Unknown / undisclosedPhase 1

Antibody–drug conjugatePhase 1

Antibody–drug conjugatePhase 1

Small moleculePhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

PRGN-3006 T Cells

Unknown / undisclosedPhase 1

Protein / enzyme therapeuticPhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

RadiopharmaceuticalPhase 1

Small moleculePhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Biologic — subtype unspecifiedPhase 1

RNA / oligonucleotidePhase 1

Small moleculePhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Small moleculePhase 1

RNA / oligonucleotidePhase 1

Multispecific antibodyPhase 1

Unknown / undisclosedPhase 1

Biologic — subtype unspecifiedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Rabeprazol sodium

Unknown / undisclosedPhase 1No recent activity

Small moleculePhase 1

Unknown / undisclosedPhase 1

Risperidone (QUAR)

Small moleculePhase 1

Small moleculePhase 1

Multispecific antibodyPhase 1

RNA / oligonucleotidePhase 1

Biologic — subtype unspecifiedPhase 1

Biologic — subtype unspecifiedPhase 1

Biologic — subtype unspecifiedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Cell therapyPhase 1

Small moleculePhase 1

SER-252 (PEOZ-apomorphine)

Small moleculePhase 1

RNA / oligonucleotidePhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Biologic — subtype unspecifiedPhase 1

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Multispecific antibodyPhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1

Multispecific antibodyPhase 1

Small moleculePhase 1No recent activity

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Cell therapyPhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Monoclonal antibodyPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Monoclonal antibodyPhase 1

Small moleculePhase 1No recent activity

Small moleculePhase 1

Antibody–drug conjugatePhase 1

Multispecific antibodyPhase 1

Small moleculePhase 1

Antibody–drug conjugatePhase 1

Multispecific antibodyPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1No recent activity

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Small moleculePhase 1

Tolododekin Alfa

Small moleculePhase 1

Small moleculePhase 1No recent activity

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1

Cell therapyPhase 1

Biologic — subtype unspecifiedPhase 1No recent activity

Small moleculePhase 1

Cell therapyPhase 1

Unknown / undisclosedPhase 1

Unknown / undisclosedPhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Cell therapyPhase 1

Small moleculePhase 1

Gene therapy / editingPhase 1

Gene therapy / editingPhase 1

Small moleculePhase 1

Multispecific antibodyPhase 1

Small moleculePhase 1

Small moleculePhase 1

Antibody–drug conjugatePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Cell therapyPhase 1No recent activity

Vasa Therapeutics VS-041

Small moleculePhase 1

Biologic — subtype unspecifiedPhase 1No recent activity

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Unknown / undisclosedPhase 1

Small moleculePhase 1

Small moleculePhase 1

Protein / enzyme therapeuticPhase 1

Biologic — subtype unspecifiedPhase 1

Unknown / undisclosedPhase 1

Multispecific antibodyPhase 1

Unknown / undisclosedPhase 1

Biologic — subtype unspecifiedPhase 1

Unknown / undisclosedPhase 1No recent activity

Small moleculePhase 1

Small moleculePhase 1

Cell therapyPhase 1

anti-CI135 CAR-T

Unknown / undisclosedPhase 1

Cell therapyPhase 1No recent activity

Multispecific antibodyPhase 1

exendin-4 Fc fusion (JY09)

Protein / enzyme therapeuticPhase 1

Small moleculePhase 1

Cell therapyPhase 1No recent activity

Cell therapyPhase 1

Small moleculePhase 1

Small moleculePhase 1

mulberry twig alkaloids

BotanicalPhase 1

sNN0029 infusion solution

Unknown / undisclosedPhase 1No recent activity

tofacitinib (Chong Kun Dang)

Unknown / undisclosedPhase 1No recent activity